170 related articles for article (PubMed ID: 16542188)
1. Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder.
Sachs G; Bowden C; Calabrese JR; Ketter T; Thompson T; White R; Bentley B
Bipolar Disord; 2006 Apr; 8(2):175-81. PubMed ID: 16542188
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
[TBL] [Abstract][Full Text] [Related]
3. Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies.
Frye MA; Yatham L; Ketter TA; Goldberg J; Suppes T; Calabrese JR; Bowden CL; Bourne E; Bahn RS; Adams B
Acta Psychiatr Scand; 2009 Jul; 120(1):10-3. PubMed ID: 19183414
[TBL] [Abstract][Full Text] [Related]
4. Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.
Bowden CL; Calabrese JR; Ketter TA; Sachs GS; White RL; Thompson TR
Am J Psychiatry; 2006 Jul; 163(7):1199-201. PubMed ID: 16816224
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6).
Licht RW; Nielsen JN; Gram LF; Vestergaard P; Bendz H
Bipolar Disord; 2010 Aug; 12(5):483-93. PubMed ID: 20712749
[TBL] [Abstract][Full Text] [Related]
7. Maintenance treatment outcomes in older patients with bipolar I disorder.
Sajatovic M; Gyulai L; Calabrese JR; Thompson TR; Wilson BG; White R; Evoniuk G
Am J Geriatr Psychiatry; 2005 Apr; 13(4):305-11. PubMed ID: 15845756
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
[TBL] [Abstract][Full Text] [Related]
9. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.
Calabrese JR; Goldberg JF; Ketter TA; Suppes T; Frye M; White R; DeVeaugh-Geiss A; Thompson TR
Biol Psychiatry; 2006 Jun; 59(11):1061-4. PubMed ID: 16769295
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
McIntyre RS
Clin Ther; 2010; 32 Suppl 1():S32-8. PubMed ID: 20152551
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.
Calabrese JR; Huffman RF; White RL; Edwards S; Thompson TR; Ascher JA; Monaghan ET; Leadbetter RA
Bipolar Disord; 2008 Mar; 10(2):323-33. PubMed ID: 18271912
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine.
van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
Acta Psychiatr Scand; 2010 Sep; 122(3):246-54. PubMed ID: 20136801
[TBL] [Abstract][Full Text] [Related]
14. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
Goodwin GM; Bowden CL; Calabrese JR; Grunze H; Kasper S; White R; Greene P; Leadbetter R
J Clin Psychiatry; 2004 Mar; 65(3):432-41. PubMed ID: 15096085
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392).
Carlson BX; Ketter TA; Sun W; Timko K; McQuade RD; Sanchez R; Vester-Blokland E; Marcus R
Bipolar Disord; 2012 Feb; 14(1):41-53. PubMed ID: 22329471
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.
Maina G; Albert U; Rosso G; Bogetto F
J Clin Psychiatry; 2008 Apr; 69(4):609-16. PubMed ID: 18294024
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
18. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Nasrallah HA; Brecher M; Paulsson B
Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
Bipolar Disord; 2011 Feb; 13(1):111-7. PubMed ID: 21320258
[TBL] [Abstract][Full Text] [Related]
20. Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials.
Frye MA; Yatham LN; Calabrese JR; Bowden CL; Ketter TA; Suppes T; Adams BE; Thompson TR
J Clin Psychiatry; 2006 Nov; 67(11):1721-8. PubMed ID: 17196051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
